CTEV

Claritev Corp
7 filings tracked
healthcarehealthcare data analyticsMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Claritev is demonstrating a strong operational core, evidenced by a 5.8% increase in quarterly revenue to $244.7 million.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The financial reality for Claritev is characterized by a precarious balance sheet and accelerating cash outflows. The company is burdened by a massive $4.6 billion debt load, which generated nearly $100 million in interest expenses this quarter alone.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every CTEV filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing reveals a company at a crossroads, where impressive top-line growth and strong Adjusted EBITDA are locked in a struggle with a crushing debt load. The 8.4% growth in Claims Intelligence proves that the product is winning in the market, but the cost of servicing the balance sheet is eroding the benefits of that growth. The divergence between the $146.9 million Adjusted EBITDA and the $73.6 million net loss highlights the extreme impact of non-cash amortization and high interest rates. Ultimately, the investment thesis depends on whether the 'Vision 2030' transformation can deliver operational efficiencies fast enough to offset the interest burden and the risks associated with extreme client concentration. While the company remains in compliance with its debt covenants, the negative operating cash flow suggests that the path to stability is narrower than management suggests. Investors must weigh the high-margin potential of the analytics business against the systemic risks of a highly leveraged capital structure.

Selected Quarter

Core Takeaway

Claritev's core business is growing and profitable on an adjusted basis, but the company is struggling with massive interest payments and a negative cash flow profile.

Investor Lens

The trade-off is between the company's proven ability to generate adjusted cash flow and its ability to service a massive debt pile without further dilution or distress.

Watch Next

The remediation of IT material weaknesses and the outcome of the centralized antitrust litigation in the Northern District of Illinois.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.25Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%
bearishMay 7

Net loss of $73.6 million driven by massive interest expenses and non-cash charges.

earnings miss
70%
bullishMay 7

Adjusted EBITDA grew to $146.9 million, showing strong underlying operational profitability.

margin expansion
60%
bearishMay 7

Negative operating cash flow and high debt may necessitate future equity raises.

dilution risk
40%
bearishMay 7

Ongoing antitrust class action litigation regarding out-of-network reimbursements.

regulatory action
50%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing reveals a company at a crossroads, where impressive top-line growth and strong Adjusted EBITDA are locked in a struggle with a crushing debt load. The 8.4% growth in Claims Intelligence proves that the product is winning in the market, but the cost of servicing the balance sheet is eroding the benefits of that growth. The divergence between the $146.9 million Adjusted EBITDA and the $73.6 million net loss highlights the extreme impact of non-cash amortization and high interest rates. Ultimately, the investment thesis depends on whether the 'Vision 2030' transformation can deliver operational efficiencies fast enough to offset the interest burden and the risks associated with extreme client concentration. While the company remains in compliance with its debt covenants, the negative operating cash flow suggests that the path to stability is narrower than management suggests. Investors must weigh the high-margin potential of the analytics business against the systemic risks of a highly leveraged capital structure.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.